In this study, we investigated the predictive value of textural features derived from CT and volume-based parameters derived from 18F-FDG-PET/CT in comparison to serologic markers in patients with DLBCL undergoing CD19-CAR-T cell therapy. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.